RenovoRx Inc expected to post a loss of 14 cents a share - Earnings Preview

RenovoRx

10/05/2024 14:03

* RenovoRx Inc  RNXT.OQ   RNXT.O  is expected to show no
change in
quarterly revenue when it reports  results on May 13 (estimated)
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for RenovoRx Inc is for a
loss
of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for RenovoRx
Inc is
$4.00​, above​ its last closing price of $1.35. ​​​

This summary was machine generated May 10 at 13:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)